GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NFL Biosciences SA (XPAR:ALNFL) » Definitions » Accounts Payable

NFL Biosciences (XPAR:ALNFL) Accounts Payable : €2.16 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is NFL Biosciences Accounts Payable?

NFL Biosciences's Accounts Payable for the quarter that ended in Dec. 2023 was €2.16 Mil.

NFL Biosciences's quarterly Accounts Payable increased from Dec. 2022 (€1.19 Mil) to Jun. 2023 (€2.21 Mil) but then declined from Jun. 2023 (€2.21 Mil) to Dec. 2023 (€2.16 Mil).

NFL Biosciences's annual Accounts Payable increased from Dec. 2021 (€0.12 Mil) to Dec. 2022 (€1.19 Mil) and increased from Dec. 2022 (€1.19 Mil) to Dec. 2023 (€2.16 Mil).


NFL Biosciences Accounts Payable Historical Data

The historical data trend for NFL Biosciences's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NFL Biosciences Accounts Payable Chart

NFL Biosciences Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable
Get a 7-Day Free Trial 0.03 0.04 0.12 1.19 2.16

NFL Biosciences Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Accounts Payable Get a 7-Day Free Trial 0.12 0.53 1.19 2.21 2.16

NFL Biosciences Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


NFL Biosciences Accounts Payable Related Terms

Thank you for viewing the detailed overview of NFL Biosciences's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


NFL Biosciences (XPAR:ALNFL) Business Description

Traded in Other Exchanges
Address
199 rue Helene Boucher, Castelnau-le-Lez, FRA, 34170
NFL Biosciences SA specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents. NFL-101 is company's core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.

NFL Biosciences (XPAR:ALNFL) Headlines

No Headlines